# Colchicine for Diabetic Nephropathy Trial

> **NCT02442921** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Diabetic Nephropathies

## Interventions

- **DRUG:** Colchicine
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02442921
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02-22
- **Primary completion:** 2019-04-30
- **Final completion:** 2019-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2017-05-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02442921

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02442921, "Colchicine for Diabetic Nephropathy Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02442921. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*